Esmolol effects on propofol requirement for hysterectomy

Esmolol effects on propofol requirement for total abdominal hysterectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200928048871N1

Enrollment

Registered

2020-11-20

Start date

2019-09-22

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients who undergo hysterectomy.

Interventions

Intervention 1: Intervention group: group one is an interventional group. 0.5 mg/kg/min esmolol will be injected for loading dose and 50 micro gram/kg esmolol will be infused till end of surgery. Inte

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ASA I and ASA II individuals who are having total abdominal hysterectomy

Exclusion criteria

Exclusion criteria: beta blocker use contraindicatied drugs and alcohol usage thyroid problems

Design outcomes

Primary

Measure	Time frame
The amount of propofol injected during the surgery. Timepoint: from the beginning till the end of surgery continuously. Method of measurement: measuring of the injected propofol.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTARANEH SARDARI

Tehran University of Medical Sciences

srd.taraneh@gmai.com+98 21 8807 6234

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026